Suchergebnisse - "LoRusso, Patricia M"

PubPharm (328)

1

A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Yap, T. | LoRusso, P. | Wong, D. | +19

CommentIn: Clin Cancer Res. 2023 Mar 1;29(5):835-837. - PMID 36534010

2

Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials

enthalten in: Journal of the National Cancer Institute | 2023

von LoRusso, P. | Freidlin, B.

CommentOn: J Natl Cancer Inst. 2023 Feb 8;115(2):174-180. - PMID 36448689

3

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer : The Results From National Cancer Institute 9984

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kim, J. | McKay, R. | Radke, M. | +21

4

Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer

enthalten in: Science translational medicine | 2023

von Budhraja, K. | McDonald, B. | Stephens, M. | +19

5

Analysis of fragment ends in plasma DNA from patients with cancer

enthalten in: bioRxiv.org | 2022

von Budhraja, K. | McDonald, B. | Stephens, M. | +19

6

Chromatin-Bound PARP1 Correlates with Upregulation of Inflammatory Genes in Response to Long-Term Treatment with Veliparib

enthalten in: bioRxiv.org | 2022

von Alvarado-Cruz, I. | Mahmoud, M. | Khan, M. | +17

7

Correction : A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Atrafi, F. | Boix, O. | Subbiah, V. | +14

ErratumFor: Clin Cancer Res. 2021 Dec 1;27(23):6366-6375. - PMID 34518310

8

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

enthalten in: Cancer discovery | 2022

von Muik, A. | Garralda, E. | Altintas, I. | +35

CommentIn: Cancer Discov. 2022 May 2;12(5):1184-1186. - PMID 35491648

9

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors : a phase I study

enthalten in: Journal for immunotherapy of cancer | 2022

von Naing, A. | Powderly, J. | Nemunaitis, J. | +11

ErratumIn: J Immunother Cancer. 2022 Oct;10(10):. - PMID 36283739

10

A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Atrafi, F. | Boix, O. | Subbiah, V. | +14

ErratumIn: Clin Cancer Res. 2022 Jul 1;28(13):2969. - PMID 35775194

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]